- Products
- Brighter future, by specialized research.
- Seomoktae extracts (BeanOptin®)
- Glycine max
-
- Ingredient name
- Seomoktae extracts (BeanOptin®)
-
- Origin
- Glycine max
-
- Daily dose
- 500 - 1,500 mg/day
-
- Appearance
- A purple-hued powder with
a distinctive aroma and flavor
-
Features
Help to increase tears and protect cornea and lacrimal glands.
-
2024 Clinical Trial Completed for Improving Dry Eye Syndrome
2022 Supported for the New Product Development Project with Purchase Conditions by the Ministry of SMEs and Startups
2020 Selected Convergence Technologies Program for Educating Creative Global Leader in Ministry of Agriculture, Food and Affairs
2020 1st for the 2020 Patent Technology Award by the Korean Intellectual Patent Office (BeanOptin®)
2020 Licensing-in from Dong-eui university
2020 National research foundation of Korea project
-
Patents
10-1835227 Composition for preventing or treating ocular disease containing Rhynchosia nulubilis
-
Paper
Current Eye Research, 1021-1029, 2024
European Journal of Pharmaceutical and Medical Research, 4(10), 2017, 147-151.
